Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM26P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,544
Award facts
- Contract value 100% obligated
- $42,543.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,543.56 on December 15, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL). This firm fixed-price delivery order, with completion targeted for December 16, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies supporting military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor primarily for the Defense Logistics Agency's Medical Supply Chain. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Dupixent is a biologic medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. The delivery order reflects AmerisourceBergen's demonstrated capability to fulfill specialized pharmaceutical procurement requirements for federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through open competition.
Quick answers
Who was awarded contract SPE2DR26FM26P?
SPE2DR26FM26P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FM26P worth?
The government has obligated $42,544 on SPE2DR26FM26P.
Is contract SPE2DR26FM26P an order under another contract?
Yes. SPE2DR26FM26P is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM26P competed?
The extent of competition for SPE2DR26FM26P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award